Warning! GuruFocus detected
4 Severe warning signs
with TIL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Instil Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US45783C1018
Description
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FR?, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.3 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | -1.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 30.9 | |||||
| 3-Year EPS without NRI Growth Rate | 36.5 | |||||
| 3-Year FCF Growth Rate | 33.3 | |||||
| 3-Year Book Growth Rate | -32.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.85 | |||||
| 9-Day RSI | 40.37 | |||||
| 14-Day RSI | 42.9 | |||||
| 3-1 Month Momentum % | 7.33 | |||||
| 6-1 Month Momentum % | -66.61 | |||||
| 12-1 Month Momentum % | 87.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.76 | |||||
| Quick Ratio | 15.76 | |||||
| Cash Ratio | 14.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -0.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -38.12 | |||||
| ROA % | -25.35 | |||||
| ROIC % | -37.23 | |||||
| 3-Year ROIIC % | -772.31 | |||||
| ROC (Joel Greenblatt) % | -48.77 | |||||
| ROCE % | -23.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.69 | |||||
| EV-to-EBIT | -1.54 | |||||
| EV-to-Forward-EBIT | -0.82 | |||||
| EV-to-EBITDA | -1.63 | |||||
| EV-to-FCF | -1.83 | |||||
| Price-to-Net-Current-Asset-Value | 3.85 | |||||
| Price-to-Net-Cash | 6.09 | |||||
| Earnings Yield (Greenblatt) % | -64.94 | |||||
| FCF Yield % | -47.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TIL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Instil Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.39 | ||
| Beta | 1.83 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.5 | ||
| Volatility % | 395.24 | ||
| 14-Day RSI | 42.9 | ||
| 14-Day ATR ($) | 2.043136 | ||
| 20-Day SMA ($) | 19.1045 | ||
| 12-1 Month Momentum % | 87.94 | ||
| 52-Week Range ($) | 9.62 - 92 | ||
| Shares Outstanding (Mil) | 6.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Instil Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Instil Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Instil Bio Inc Frequently Asked Questions
What is Instil Bio Inc(TIL)'s stock price today?
The current price of TIL is $17.89. The 52 week high of TIL is $92.00 and 52 week low is $9.62.
When is next earnings date of Instil Bio Inc(TIL)?
The next earnings date of Instil Bio Inc(TIL) is 2025-05-09 Est..
Does Instil Bio Inc(TIL) pay dividends? If so, how much?
Instil Bio Inc(TIL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers